This FREE Master Class is brought to you by TIPS: The Infection Prevention Strategy

FULL VIDEO PRESENTATION BELOW

In the coming weeks, dental offices and other facilities will be preparing to reopen their offices. As they do so, they face the risk of exposure to patients that could be COVID-19 positive but asymptomatic.  The risk of aerosolization during dental procedures can be a risk to dental professionals and patients. This webinar will cover a literature review on the risk to  staff and patients.  We will also provide guidance on different protocols and technologies that can be implemented into a practice to address the risk.

Learning Objectives

1. Understand the  COVID-19 risks to dental staff
2. Review of the literature to understand transmission routes
3. Realize actions that dental professionals can take to minimize risk to patients and themselves working in this environment

Full video of our May 7, 2020 Webinar:

SPEAKERS:

Amber D. Riley, MS, RDH, FAAFS

Ms. Riley is a 1998 graduate of Sinclair College in Dayton, Ohio. She completed her Baccalaureate with Wright State University and Masters at Boston University. In addition to dental hygiene practice in San Diego, California, Amber is a subject matter consultant to over twenty dental boards, and she is a Forensic Dental Consultant for the San Diego County Office of the Medical Examiner. She is a Fellow of the American Academy of Forensic Sciences, Member of the California Dental Hygienists’ Association, American Society of Forensic Odontology, and an Associate Member of the American Academy for Oral Systemic Health. She lectures internationally covering evidence-based, oral-systemically focused topics for dental professionals, forensic odontology and oral pathology.

Jeff Williams, Ph.D., B.V.Sc.

Dr. Jeff Williams had a long career in academic microbiology and infectious diseases, retiring after 27 years from his position as Professor of Microbiology and Molecular Genetics at Michigan State University to found a biotechnology start-up, HaloSource Inc, in Seattle, WA in 1998. Retiring, again, in 2014, he has remained active as technical advisor to several companies in the PNW region, specializing in the areas of antimicrobial chemistry and disinfection.  Author of over 200 scientific papers and textbook chapters , he served four years as a member of the Board of Counselors to the US-NIH Institute of Allergy and Infectious Diseases, and has been a frequent consultant to the World Health Organization of the UN in Geneva, Switzerland. Jeff was elected Fellow of the American Association for the Advancement of Science (AAAS) in 1996, and served as retained consultant to first Merck Inc. (1980-82), then Pharmacia (now Pfizer Inc.) (1983-1999) on therapeutic drug discovery and development. He has a long standing interest in tropical infectious diseases, starting with his appointment as staff scientist for WHO in Argentina 1968-71, and for 15 years directed a collaborative NIH-funded Program Project on Infectious Diseases in Sudan.  He holds degrees in Veterinary Science (B.V.Sc., University of Bristol, UK, 1964), and Pathobiology (Ph.D., University of Pennsylvania, 1968), where he was a Fulbright Scholar (1964-68).

SPONSORED BY: